drugset / Trial / NCT00101725
A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is designed to evaluate the safety and effectiveness of an investigational drug, TRN-002 (crofelemer) to relieve the symptoms of diarrhea-predominant irritable bowel syndrome (IBS).
Timeline
- Start
- 2004-12
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Crofelemer | Small molecule | 125 mg | Oral |
| Subject | Crofelemer | Small molecule | 250 mg | Oral |
| Subject | Crofelemer | Small molecule | 500 mg | Oral |